Trials Sponsors Conditions Drugs Pricing

Conditions

Liver Failure Myocardial Perfusion Imaging

Outcome Measures

Primary Outcomes (1)

Cardiovascular mortality
10 years

Secondary Outcomes (2)

Major adverse cardiovascular event
10 years
All-cause mortality
10 years

Study Arms (1)

Orthotopic liver transplantation candidates

No intervention, imaging test and risk stratification as part of routine clinical care.

Procedure: Myocardial perfusion imaging

Interventions

Myocardial perfusion imagingProcedure

Orthotopic liver transplantation candidates

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Consecutive patients with end-stage liver disease were identified after referral to the Queen Elizabeth Hospital Birmingham for CV risk stratification as part of a pre-transplant screening work-up. Subjects were referred for non-invasive CV risk assessment based on the above criteria.

You may qualify if:

Liver transplantation candidates with one or more of the following:

Sponsors & Collaborators

University Hospital Birmingham NHS Foundation Trust
Otherlead

Related Publications (1)

Moody WE, Holloway B, Arumugam P, Gill S, Wahid YS, Boivin CM, Thomson LE, Berman DS, Armstrong MJ, Ferguson J, Steeds RP. Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study. J Nucl Cardiol. 2021 Dec;28(6):2876-2891. doi: 10.1007/s12350-020-02126-z. Epub 2020 May 11.
PMID: 32394403DERIVED

MeSH Terms

Conditions

Liver Failure

Condition Hierarchy (Ancestors)

Hepatic InsufficiencyLiver DiseasesDigestive System Diseases

Study Officials

Richard P Steeds, MD
University Hospital Birmingham NHS Foundation Trust
STUDY DIRECTOR

Enrollment

403 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Consultant Cardiologist with a Specialist Interest in Cardiac Imaging

Study Record Dates

First Submitted

March 4, 2019

First Posted

March 6, 2019

Study Start

September 2007

Actual (reported)

Myocardial Perfusion Imaging in Liver Transplantation Candidates

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Orthotopic liver transplantation candidates

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Related Publications (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Orthotopic liver transplantation candidates

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Related Publications (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record